Learn about CVE-2020-27258, an information disclosure vulnerability in SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i, and AnyDana-A. Find out the impact, affected systems, exploitation mechanism, and mitigation steps.
SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i, and AnyDana-A are affected by an information disclosure vulnerability in the communication protocol of the insulin pump and its mobile applications. This vulnerability allows unauthenticated attackers to extract the pump's keypad lock PIN via Bluetooth Low Energy.
Understanding CVE-2020-27258
This CVE identifies an information disclosure vulnerability in specific medical devices that could compromise sensitive data.
What is CVE-2020-27258?
The vulnerability in the communication protocol of the insulin pump and its mobile applications enables unauthorized individuals to retrieve the pump's keypad lock PIN through Bluetooth Low Energy.
The Impact of CVE-2020-27258
The vulnerability poses a risk of exposing sensitive information, potentially compromising the security and privacy of individuals using the affected medical devices.
Technical Details of CVE-2020-27258
This section delves into the technical aspects of the vulnerability.
Vulnerability Description
The vulnerability allows unauthenticated attackers to extract the pump's keypad lock PIN via Bluetooth Low Energy due to insufficiently protected credentials.
Affected Systems and Versions
Exploitation Mechanism
Attackers can exploit the vulnerability by leveraging the communication protocol of the insulin pump and its associated mobile applications to extract the keypad lock PIN.
Mitigation and Prevention
Protecting against and addressing the vulnerability is crucial for ensuring the security of the affected devices.
Immediate Steps to Take
Long-Term Security Practices
Patching and Updates